Literature DB >> 7930766

Preoperative radiochemotherapy and radical surgery in comparison with radical surgery alone. A prospective, multicentric, randomized DOSAK study of advanced squamous cell carcinoma of the oral cavity and the oropharynx (a 3-year follow-up).

C Mohr1, W Bohndorf, J Carstens, F Härle, J E Hausamen, H Hirche, H Kimmig, J Kutzner, J Mühling, J Reuther.   

Abstract

A multicentric, randomized study of squamous cell carcinoma (SCC) of the oral cavity and the oropharynx has been undertaken by DOSAK. The results after radical surgery alone have been compared with the results of combined preoperative radiochemotherapy followed by radical surgery. Patients with primary (biopsy proven) SCC of the oral cavity or the oropharynx with tumor nodes metastasis (TNM) stages T2-4, N0-3, M0 were included in the study. A total of 141 patients were treated by radical surgery alone, whereas 127 patients were treated by radical surgery preceded by preoperative radiochemotherapy. The preoperative treatment consisted of conventionally fractioned irradiation on the primary and the regional lymph nodes with a total dose of 36 Gy (5 x 2 Gy per week) and low-dose cisplatin chemotherapy with 5 x 12.5 mg cisplatin per m2 of body surface during the first week of treatment. Radical surgery according to the DOSAK definitions (DOSAK, 1982) was performed after a delay of 10-14 days. During the follow-up period, 28.2% of all patients suffered from locoregional recurrence, and 27.2% of the patients died. The percentages were higher after radical surgery alone for locoregional recurrence (31% and 15.6%) and for death (28% and 18.6%). The life-table analysis showed improved survival rates of 4.5% after 1 year and 8.3% after 2 years in the group of patients treated with combined therapy. The demonstrated improvement appeared to be significant with the Gehan-Wilcoxon test as well as with the log rank test below a P value of 5%.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7930766     DOI: 10.1016/s0901-5027(05)80288-7

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  20 in total

1.  Functional outcome after different oncological interventions in head and neck cancer patients.

Authors:  Thomas Mücke; Janett Koschinski; Stefan Wagenpfeil; Klaus-Dietrich Wolff; Anastasios Kanatas; David A Mitchell; Herbert Deppe; Marco R Kesting
Journal:  J Cancer Res Clin Oncol       Date:  2011-12-06       Impact factor: 4.553

2.  Combined-modality treatment in advanced oral squamous cell carcinoma: Primary surgery followed by adjuvant concomitant radiochemotherapy.

Authors:  Matthias Kreppel; Uta Drebber; Hans-Theodor Eich; Timo Dreiseidler; Joachim E Zöller; Rolf-Peter Müller; Martin Scheer
Journal:  Strahlenther Onkol       Date:  2011-03-14       Impact factor: 3.621

3.  Head and neck reconstruction using microsurgery: a 9-year retrospective study.

Authors:  G H Holom; H Seland; E Strandenes; P G Liavaag; S Lybak; S Løes; K Tornes; H N Vintertun
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-02-16       Impact factor: 2.503

Review 4.  [Surgical treatment options for squamous cell carcinoma of the oral cavity].

Authors:  Michael Rasse
Journal:  Wien Med Wochenschr       Date:  2008

5.  Outcome and histopathologic regression in oral squamous cell carcinoma after preoperative radiochemotherapy.

Authors:  Oliver Driemel; Tobias Ettl; Oliver Kölbl; Torsten E Reichert; Bernd V Dresp; Jürgen Reuther; Hans Pistner
Journal:  Strahlenther Onkol       Date:  2009-05-15       Impact factor: 3.621

6.  Effectiveness of adjuvant radiotherapy in patients with oropharyngeal and floor of mouth squamous cell carcinoma and concomitant histological verification of singular ipsilateral cervical lymph node metastasis (pN1-state)--a prospective multicenter randomized controlled clinical trial using a comprehensive cohort design.

Authors:  Maximilian Moergel; Antje Jahn-Eimermacher; Frank Krummenauer; Torsten E Reichert; Wilfried Wagner; Thomas G Wendt; Jochen A Werner; Bilal Al-Nawas
Journal:  Trials       Date:  2009-12-23       Impact factor: 2.279

7.  Clinicopathological evaluation of pre-operative chemoradiotherapy with S-1 as a treatment for locally advanced oral squamous cell carcinoma.

Authors:  Shintaro Kawano; Yanqun Zheng; Kazunari Oobu; Ryota Matsubara; Yuichi Goto; Toru Chikui; Tadamasa Yoshitake; Tamotsu Kiyoshima; Teppei Jinno; Yasuyuki Maruse; Eiji Mitate; Ryoji Kitamura; Hideaki Tanaka; Takeshi Toyoshima; Tsuyoshi Sugiura; Seiji Nakamura
Journal:  Oncol Lett       Date:  2016-04-05       Impact factor: 2.967

8.  Neoadjuvant chemotherapy: does it have benefits for the surgeon in the treatment of advanced squamous cell cancer of the oral cavity?

Authors:  Lajos Olasz; József Szalma; Eniko Orsi; Tamás Tornóczky; Tamás Markó; Zoltán Nyárády
Journal:  Pathol Oncol Res       Date:  2009-09-12       Impact factor: 3.201

9.  [Evaluation of her-2/neu amplification/overexpression in OSCC with fluorescence in situ hybridization (FISH) and immunohistochemistry].

Authors:  M Scheer; W Prange; K Petmecky; P Schirmacher; J E Zöller; A C Kübler
Journal:  Mund Kiefer Gesichtschir       Date:  2003-03-07

10.  [Patients with oral squamous cell carcinoma. Long-term survival and evaluation of quality of life-initial results obtained with two treatment protocols in a prospective study].

Authors:  P Kessler; G Grabenbauer; A Leher; S Schultze-Mosgau; S Rupprecht; F W Neukam
Journal:  Mund Kiefer Gesichtschir       Date:  2004-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.